A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization - PubMed (original) (raw)
. 1997 Feb 1;89(3):823-33.
Affiliations
- PMID: 9028313
Free article
A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization
J T Arnold et al. Blood. 1997.
Free article
Abstract
Despite numerous studies investigating the action of c-mpl ligand, no reports have defined the in vivo changes in megakaryocytopoiesis in response to a single injection of this cytokine. Here we compare the kinetics of the megakaryocytopoietic response in C57BI/6J mice administered 25 micrograms/ kg or 250 micrograms/kg of pegylated (PEG) murine megakaryocyte growth and development factor (MGDF) as a single intravenous injection. Megakaryocytes of mice treated with MGDF had normal ultrastructure, showing a typical distribution of the demarcation membrane system, alpha-granules, and other cytoplasmic organelles. Megakaryocyte ploidy, size, and frequency were markedly increased with both MGDF doses. Megakaryocyte ploidy was maximally increased from a modal value of 16N to 64N on day 3, with both doses of MGDF. Similarly, a comparable increase in megakaryocyte size occurred in the two MGDF groups. Increased megakaryocyte size was coupled to the increase in megakaryocyte ploidy, and no evidence for independent regulation of megakaryocyte size within individual ploidy classes was apparent. In contrast to megakaryocyte ploidy and size, the increase in megakaryocyte frequency was markedly different with the two doses of MGDF. The proportion of 2N and 4N cells was increased from a baseline of 0.035% to 0.430% by day 4 in mice treated with the higher dose of MGDF, but only to 0.175% in mice administered 25 micrograms/kg of MGDF. The marked increase in the pool of these immature megakaryocytes translated to a sustained elevation in the frequency of polyploid megakaryocytes (8N cells and greater). In contrast to the sustained increase in the frequency of polyploid cells, the level of polyploidization was downregulated on days 6 to 10, but normalized by day 14. We conclude that a single injection of MGDF is able to expand the megakaryocytic pool in a dose-dependent manner, which, with subsequent maturation, should lead to an increased rate of platelet production.
Similar articles
- Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates.
Harker LA, Hunt P, Marzec UM, Kelly AB, Tomer A, Hanson SR, Stead RB. Harker LA, et al. Blood. 1996 Mar 1;87(5):1833-44. Blood. 1996. PMID: 8634430 - Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons.
Andrews RG, Winkler A, Myerson D, Briddell RA, Knitter GH, McNiece IK, Hunt P. Andrews RG, et al. Stem Cells. 1996 Nov;14(6):661-77. doi: 10.1002/stem.140661. Stem Cells. 1996. PMID: 8948024 - Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
Harker LA, Marzec UM, Hunt P, Kelly AB, Tomer A, Cheung E, Hanson SR, Stead RB. Harker LA, et al. Blood. 1996 Jul 15;88(2):511-21. Blood. 1996. PMID: 8695799 - Measurement of megakaryocyte frequency and ploidy distribution in unfractionated murine bone marrow.
Corash L, Levin J, Mok Y, Baker G, McDowell J. Corash L, et al. Exp Hematol. 1989 Mar;17(3):278-86. Exp Hematol. 1989. PMID: 2465169 Review. - Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis.
Neumann TA, Foote M. Neumann TA, et al. Cytokines Cell Mol Ther. 2000 Mar;6(1):47-56. doi: 10.1080/13684730050515912. Cytokines Cell Mol Ther. 2000. PMID: 10976539 Review.
Cited by
- Utilization of imaging flow cytometry to define intermediates of megakaryopoiesis in vivo and in vitro.
McGrath KE. McGrath KE. J Immunol Methods. 2015 Aug;423:45-51. doi: 10.1016/j.jim.2015.03.002. Epub 2015 Mar 17. J Immunol Methods. 2015. PMID: 25795419 Free PMC article. - SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury.
Niswander LM, Fegan KH, Kingsley PD, McGrath KE, Palis J. Niswander LM, et al. Blood. 2014 Jul 10;124(2):277-86. doi: 10.1182/blood-2014-01-547638. Epub 2014 Apr 15. Blood. 2014. PMID: 24735964 Free PMC article. - Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
Ng AP, Kauppi M, Metcalf D, Hyland CD, Josefsson EC, Lebois M, Zhang JG, Baldwin TM, Di Rago L, Hilton DJ, Alexander WS. Ng AP, et al. Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5884-9. doi: 10.1073/pnas.1404354111. Epub 2014 Apr 7. Proc Natl Acad Sci U S A. 2014. PMID: 24711413 Free PMC article. - The biology of thrombopoietin and thrombopoietin receptor agonists.
Kuter DJ. Kuter DJ. Int J Hematol. 2013 Jul;98(1):10-23. doi: 10.1007/s12185-013-1382-0. Epub 2013 Jul 3. Int J Hematol. 2013. PMID: 23821332 Review. - Role of tumor suppressor p53 in megakaryopoiesis and platelet function.
Apostolidis PA, Woulfe DS, Chavez M, Miller WM, Papoutsakis ET. Apostolidis PA, et al. Exp Hematol. 2012 Feb;40(2):131-42.e4. doi: 10.1016/j.exphem.2011.10.006. Epub 2011 Oct 21. Exp Hematol. 2012. PMID: 22024107 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases